par Cremer, Anneline
;Demetter, Pieter
;De Vos, Martine;Rahier, Jean François;Baert, Filip;Moreels, Tom;Macken, Elisabeth;Louis, Edouard;Ferdinande, Liesbeth;Fervaille, Caroline;Dedeurwaerdere, Franceska;Bletard, Noela;Driessen, Ann;De Hertogh, Gert;Vermeire, Séverine;Franchimont, Denis
;Belgian Inflammatory Bowel Disease Research and Development (BIRD) Group,
Référence Clinical gastroenterology and hepatology
Publication Publié, 2019-06-01



Référence Clinical gastroenterology and hepatology
Publication Publié, 2019-06-01
Article révisé par les pairs
Résumé : | Patients with inflammatory bowel diseases (IBD) have increased risks of dysplasia and colitis-associated cancer (CAC). We evaluated the risk of development of high-grade dysplasia (HGD) or CAC after diagnosis of dysplasia using data from a national cohort of patients with IBD. |